TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 123 filers reported holding TG THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,194,439 | -66.5% | 382,110 | -0.5% | 0.00% | -66.7% |
Q2 2023 | $9,542,037 | +121130.3% | 384,140 | -26.6% | 0.00% | 0.0% |
Q1 2023 | $7,871 | +9.9% | 523,337 | -13.5% | 0.00% | 0.0% |
Q4 2022 | $7,159 | -99.8% | 605,147 | +15.9% | 0.00% | +200.0% |
Q3 2022 | $3,090,000 | +92.3% | 522,029 | +38.1% | 0.00% | 0.0% |
Q2 2022 | $1,607,000 | -58.3% | 378,007 | -4.9% | 0.00% | 0.0% |
Q1 2022 | $3,856,000 | -46.6% | 397,559 | -14.0% | 0.00% | -50.0% |
Q4 2021 | $7,222,000 | -67.0% | 462,058 | -33.9% | 0.00% | -71.4% |
Q3 2021 | $21,869,000 | -14.4% | 699,119 | +6.2% | 0.01% | -12.5% |
Q2 2021 | $25,545,000 | -21.7% | 658,532 | -2.7% | 0.01% | -20.0% |
Q1 2021 | $32,613,000 | -16.3% | 676,609 | -9.6% | 0.01% | -23.1% |
Q4 2020 | $38,942,000 | +95.9% | 748,604 | +0.8% | 0.01% | +62.5% |
Q3 2020 | $19,879,000 | +137.8% | 742,884 | +73.1% | 0.01% | +166.7% |
Q2 2020 | $8,361,000 | +34.3% | 429,214 | -32.2% | 0.00% | 0.0% |
Q1 2020 | $6,226,000 | +79.0% | 632,713 | +101.8% | 0.00% | +200.0% |
Q4 2019 | $3,479,000 | +107.8% | 313,458 | +5.2% | 0.00% | 0.0% |
Q3 2019 | $1,674,000 | -34.7% | 298,008 | +0.6% | 0.00% | 0.0% |
Q2 2019 | $2,562,000 | – | 296,186 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |